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WHAT THIS PAPER ADDS
 Estimation of walking distance is essential to deﬁne the severity of claudication and is readily accessible through patient’s inter-
view. The widely used Walking Impairment Questionnaire (WIQ) and the recently proposed Estimated Ambulatory Capacity By
History-Questionnaire (EACH-Q) both include an item related to running capacity. The present results show that most patients
complaining claudication report to be unable to run. Thereby, we advocate that questions about running capacity should likely be
removed from these questionnaires. Future studies are required to propose new questionnaires, or modify existing tools, for the
routine evaluation of maximal walking distance by history.a r t i c l e i n f o
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Objective: The Estimating Ambulation Capacity by History-Questionnaire (EACH-Q) and the Walking
Impairment Questionnaire (WIQ) are used to estimate maximal walking distance (MWD). The EACH-Q
and WIQ included 4 and 14 items respectively, among which one item dealing with running capacity.
We hypothesised that this item was of little interest in patients with claudication.
Design: The WIQ and EACH-Q were self-completed and corrected before a constant load (3.2 km h1; 10%
slope) treadmill tests, maximised to 15 min.
Patients: 371 patients (298 males/73 females, 62.9  11.2 years).
Methods: The number of errors (duplicate, absent or paradoxical answers to one item) and correlation of
questionnaire scores with MWD on treadmill were calculated, before and after skipping the answer to
the running item.
Results: The proportion of questionnaires with errors was 27% with the EACH-Q and 48% with the WIQ.
Two-hundred and twenty-one (59.6%) and 245 (66%) out of 371 patients reported to be unable to run, for
the EACH-Q andWIQ, respectively. The rate of errors was reduced by 15% for the EACH-Q (p < 0.05) when
skipping the running item for scoring. The correlation coefﬁcients between the MWD and the ques-
tionnaire scores were 0.449 and 0.485 for the EACH-Q and were 0.571 and 0.572 for the WIQ, before and
after skipping the running item, respectively.
Conclusion: Most of our patients reported to be unable to run and skipping the running item reduce the
rate of errors in self-completing the questionnaires without impairing the correlation of questionnaire
scores with treadmill results. It is likely that the running item could be removed from theWIQ and EACH-
Q questionnaires.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Vascular Investigations, University Hospital, 4 rue Larrey, Angers Cedex 09 F-49933, France. Tel.: þ33 2 41 35 40 93;
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lar and Endovascular Surgery 43 (2012) 705e710The maximal walking distance (MWD: the distance walked at
a usual pace until pain forces the patient to stop) is a key element in
speed. The item on running capacity is the fourth item. For each
item, the patient was asked to choose the longest duration thatN. Ouedraogo et al. / European Journal of Vascu706assessing the severity of intermittent claudication. Objective
measurement of the MWD performed on a treadmill may not be
feasible (e.g., no treadmill available, telephone survey, time or cost
constrains). Further, self-report of the MWD by history is essential
to approach the perception of walking disability by the patient. It
has been suggested that non-standardised estimation of walking
capacity is inherently unreliable.1 To standardise self-reports of
functional capacity, self-completed questionnaires are used in
patients with intermittent claudication. An ideal standard ques-
tionnaire for routine clinical use should be (amongst others)
simple, short, easy to remember and easily scored by mental
calculation. To date, no available questionnaire fulﬁls these criteria,
advocating for further research on questionnaires to estimate
walking capacity, speciﬁcally for routine clinical practice.
Among standard questionnaires is the 14-item Walking
Impairment Questionnaire (WIQ). Unfortunately, the WIQ faces
a high rate of errors when self-completed2 and its relatively
complex scoring limits its diffusion as a routine tool. The four-item
Estimating Ambulation Capacity by History-Questionnaire (EACH-
Q) was recently proposed that is relatively simpler to score.3 Both
include one item dealing with running capacity.2e4 Most elderly
patients in the general population do not run,5,6 raising concerns
about the usefulness of an item dealing with running, speciﬁcally in
elderly patients with claudication. When using questionnaires, it is
recommended to use the shortest questionnaire provided that it
does not compromise the data collection requirements of the trial.7
We hypothesised that when using the EACH-Q and the WIQ
questionnaires, (i) most patients with claudicationwill report to be
unable to run, (ii) skipping the item about running capacity would
reduce the number of errors observed after self-completion. (iii)
scoring after skipping the running item would not impair the
concordance of questionnaire scores with objective measurements
of MWD on treadmill as compared to the score including the
running item.Methods
Study population
Aprospective studywas performed among all newadult patients
referred to the laboratory for treadmill walking tests for vascular-
type claudication. Vascular-type claudication refers to a lower-
limb pain or discomfort, absent at rest, occurring at exercise and
recovering within 10 min when exercise is stopped (regardless of
theMWD). Inclusion criteria were native French language, ability to
work on treadmill and ability to read the questionnaires alone (if
necessary reading lens were provided). Exclusion criteria were
psychiatric disorders and critical limb ischaemia. The study
complies with the ethical rules for human experimentation that are
stated in the Declaration of Helsinki, was approved by the ethics
committee, promoted by the university hospital in Angers and
recorded in the NIH database (http://clinicaltrials.gov) under
reference NCT1114178. Signed approval to participate was obtained
from all included subjects. Thereafter, patients were provided
a black or blue pen and asked to self-complete the two question-
naires (theWIQ and the EACH-Q) while in the waiting room, before
their admission for the treadmill test.Questionnaires
We used a French version of the EACH-Q.3 In brief, the EACH-Q
includes four items which correspond to a different displacementcould be performed easily: answers ranged from ‘impossible’ to ‘3 h
or more’. The value attributed to the duration response was 0 for
“impossible” and up to 7 for ‘3 h ormore’. The following coefﬁcients
are used for each item: 1 for ‘slow walk’, 2 for ‘normal walk’, 4 for
‘fast walk’ and 7.286 for ‘run’.3 The score was calculated for each
displacement speed by multiplying the corresponding coefﬁcient
by the value attributed to the duration response.
A French version of the WIQ was used.2,8 In brief, The WIQ
includes 14 items relating to the difﬁculty in performing a ﬁxed
distance at usual pace (n ¼ 7), performing a ﬁxed distance at
different displacement speed (n ¼ 4) and climbing stair ﬂights
(n ¼ 3). The item on running capacity is the eleventh item. For each
item, the degree of difﬁculty is attributed a value from 0 (impos-
sible) to 4 (no difﬁculty). A weight is attributed for each item. The
product of weight by the degree of difﬁculty is calculated for each
item and the subscale score is the sum of these products divided by
the highest possible score, which is 14,080, 46 and 288 for distance,
speed and stair climbing, respectively. The subscale scores are then
multiplied by 100 to give percentage of values. The overall WIQ
score is the mean value of the three subscale scores (i.e., [distance
score þ speed score þ stair-climbing score]/3).
Correction of questionnaires
At admission in the test room and before the treadmill testing
was performed, the two questionnaires were checked for missing,
duplicate or paradoxical answers by a physician or a nurse, as
previously described.3 Missing errors are no answer to an item.
Duplicate errors are two or more answers to the same item. Para-
doxical errors are detected by comparing the item to adjacent
item(s) of the same scale (EACH-Q) or subscale WIQ and observing
that answers suggest a lower difﬁculty (WIQ) or higher duration
(EACH-Q) for a harder proposed task.When errors were found, self-
reported answers were discussed with the patient and modiﬁed or
completed with a red pen.
Treadmill testing
For the treadmill testing, 10% slope and 3.2 km h1 speed were
used. The speed was reached within 1 min to facilitate patient’s
adaptation to treadmill walking. The maximum duration of tread-
mill exercise was set to 15 min, which corresponds to a maximum
distance of 750 m, since we previously showed that only 7.5% of
patients who reach this distance would stop within the next
250m.9 Prior to starting, patients were informed that the test could
be stopped upon request at any time in the case of dizziness, severe
dyspnoea, angina or whenever lower-limb symptoms became
intolerable. During the test, patients were continuously encouraged
to walk and reminded that they should ask for the stop at maximal
pain and not when pain ﬁrst occurs. The treadmill MWD was
recorded for each patient.
Data management and scoring
We calculated the number of errors observed after self-
completion and a ﬁrst scoring was performed using the
complete corrected questionnaires. The overall EACH-Q and WIQ
scores were obtained according to our earlier description.3 Then
the running question was skipped for questionnaire correction,
scoring and analysis (item 4 of the EACH-Q and item 11 of the
WIQ). These ‘modiﬁed’ questionnaire results and scorings, with
the running item skipped, were designed EACH-Q* and WIQ*. We
estimated the number of errors that would have been observed
Table 1
Characteristics of the 371 included patients.
Characteristics (mean  SD)
Age (years) 62.9  11.2
Sex, n male (%) 298 (80.3)
Height (m) 1.70  0.08
Body mass (kg) 76.5  14.4
Systolic arterial pressure (mmHg) 137  19
Diastolic arterial pressure (mmHg) 79  10
Lowest measurable ABI 0.75  0.25
Comorbid conditions and risk factors: n (%)
Cardiovascular diseases other than lower-limb PAD 190 (51.2)
Smokers 107 (28.8)
Respiratory diseases 60 (16.2)
Diabetes type 2/type 1 72 (19.4)/2 (0.5)
Suspected or operated lumbar spinal stenosis 41 (11.1)
Sciatica; lumbar arthritis and other rheumatic diseases 80 (21.6)
Treatments Number of patients (%)
Anti-platelet or anti-coagulant 276 (74.4)
Cholesterol lowering agents 242 (65.2)
Anti-hypertensive drugs 231 (62.3)
Beta-blockers 101 (27.2)
Anti-diabetic drugs 65 (17.5)
Figure 1. Distribution of the distances performed by intervals of 50 m.
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removed before completion (which was not what was done here).
It was based on the same techniques for missing and duplicate
answers, but paradoxical answers that originally included the
running item were neglected. A second scoring was performed for
the WIQ* and EACH-Q*. The EACH-Q* score was calculated by
dividing the sum of points of the remaining three items by the
maximum possible score (49) and multiply by 100. The WIQ*
score was calculated by dividing the speed-subscale value of the
remaining four subscale items by the maximum possible subscale
score (26). As for the WIQ, the total WIQ* score is the mean value
of the three subscale scores.
Data analysis
The number of errors made by patients after self-completion
was counted for the WIQ, WIQ*, EACH-Q and EACH-Q*. We
compared the number of errors observed with or without the
running item using the MacNemar test. Results are presented as
mean SD ormedian (25e75 centiles) according to normal or non-
normal distribution. Comparison of scores with, and after skipping
of, the running items was performed with theWilcoxon paired test.
The spearman ‘r’ correlation coefﬁcient was reported for the rela-
tionship between treadmill MWD and the totalWIQ,WIQ*, EACH-Q
and EACH-Q* scores, respectively. All analyses were performed
with SPSS15.0.1, and a two-tailed p < 0.05 was used to indicate
statistical signiﬁcance.
Calculation of the number of subjects
We expected that one-quarter of the EACH-Q and one-half of the
WIQ questionnaires, respectively, would show errors when self-
completed.3 We assumed that errors would be equally distributed
among the four items of the EACH-Q and the 14 items of the WIQ,
but in half of the cases would not be isolated. Thereby, mathe-
matically we expected that the proportion of questionnaires with
errors would be reduced to 22% (¼25$7/8) and 48% (¼50$27/28) for
the EACH-Q* and WIQ*, respectively. The minimal number of
patients required to show a signiﬁcant difference between
proportions before and after skipping of the running item, with
alpha 0.05 and beta 80%, were 258 and 806 respectively. Due to our
long-term goal of improving the EACH-Q questionnaire (see
Conclusions and Perspectives), we focussed only on showing
a difference between EACH-Q and EACH-Q*. In perspective of the
laboratory activity and for pragmatic reasons, we decided to
include all new patients referred to our laboratory over a 1-year
period.
Results
Population studied
Over the study period, 378 different patients with claudication
of suspected vascular origin were referred to the laboratory for
treadmill testing. Seven patients refused to participate. As shown in
Table 1, most included patients who were males, had or had been
treated for other localisations of their cardiovascular disease
(speciﬁcally at the coronary or carotid level). Among co-
morbidities, lumbar osteo-articular diseases were frequent, likely
as a result of the speciﬁc interest of our laboratory for proximal
claudication. Of the 371 patients, 308 (83%) were unable to
complete the 15 min (w750 m) of the constant-load treadmill test
(Fig. 1). The median (25e75 centiles) MWD of these 308 patients
was 170 (120e261) m.Completion and corrections of the questionnaires
The proportion of questionnaires with errors was 27% (n ¼ 101)
with the EACH-Q and 48% (n ¼ 178) with the WIQ. Speciﬁcally,
errors on the running item were observed in 57 of the EACH-Q
questionnaires among which 42 times associated with an error
on another item. For the WIQ, errors on the running item were
found in 77 questionnaires, associated to an error in another item in
all but ﬁve cases. According to our hypothesis, most patients
reported to be unable to run, according to their answer to item 4 of
the EACH-Q and to item 11 of the WIQ (Fig. 2). Nevertheless,
approximately 10% of the patients declared to be able to run easily
for 10 min or more on the EACH-Q (value 4 or more) or to be able to
run one block (w100 m, value 4) easily on the WIQ.
After skipping the running item from the questionnaires, the
rate of errors was reduced by 15% for the EACH-Q, but only by 3% for
the WIQ. We found only 86 (23%) errors within the three-item
EACH-Q* (p < 0.05 from the original four-item EACH-Q) and 173
Figure 2. Distribution of values on the running item of the EACH-Q and WIQ
questionnaire.
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item WIQ).
The skipping of the running item resulted in an increase of the
median questionnaire scores from 25 (11e42) for the EACH-Q to 43
(22e63) for the EACH-Q* (p < 0.001) and from 41 (26e59) for the
WIQ to 47 (32e68) for the WIQ* (p < 0.001) as shown in Fig. 3. The
correlation between the MWD and the questionnaire scores was
not decreased after skipping of the running item. Spearman ‘r’
coefﬁcients of correlation were 0.449 for the EACH-Q and 0.485 for
the EACH-Q* and were 0.571 for the WIQ and 0.572 for the WIQ*
(p < 0.001 for all values).Discussion
Many questionnaires may be of interest in patients with
vascular-type claudication, focussing on one or different aspects of
the disease.3,4,10e15 When using self-completed questionnaires, it
is of interest that they are as short and simple as possible to
reduce the risk of errors2,3 and the time needed for completion. In
the present study the proportion of WIQ and EACH-QFigure 3. Distribution of scores for the EACH-Q and WIQ by intequestionnaires with errors was in the range of our previous
report.3 When the running item was skipped from the question-
naires, the number of errors was reduced in both cases, although
only signiﬁcantly with the EACH-Q.
Previous studies have reported that many older adults engage in
no leisure-time physical activity. In the survey administered to US
adults, physical activity was assessed using questions about
moderate and vigorous activities that are performed during non-
working hours in a usual week. Authors found that 16% of the
respondents are inactive (no moderate or vigorous activity at any
time during a usual week) and the prevalence of inactivity is higher
at older ages, from 16% of men aged 45 to 64, up to 30% of men aged
75 or more.16 Similarly, data from the Center for Disease Control
and Prevention (CDC) indicate that about 28% of men and 34% of
women aged 65e74, 35% of men and 44% of women aged 75 or
more are inactive (http://www.cdc.gov/brfss). Assuming thatw30 s
are needed to run a distance of 100 m in untrained elderly diseased
adults, the proportion of patients reporting to be unable to run
easily 30 s (w100 m) in our study was 66% and 60% with the EACH-
Q and the WIQ, respectively. This is consistent with the results
observed in the Finnish study where the proportion of men aged
59e63 years in 1981, aged 59e63 years in 1996 and aged 58e62 in
1990 presenting disability in running a distance of 100 m is 58%,
55% and 60%, respectively.6 Last, the fact that only 28 of our patients
(7.5%) reported to be able to run at least 10 min on the EACH-Q is
concordant with the 94% proportion of running disability reported
in 688 patients with rheumatic diseases.5
Previous studies have shown that the relationship between the
questionnaire scores and objectively measured walking capacity is
fair.3,4,8,17 For example, the correlation coefﬁcient (r) between the
overall WIQ score and constant-load treadmill MWD was 0.53 for
24 patients with arterial claudication.8 In another study, the rela-
tionships between the WIQ and the EACH-Q scores and treadmill
MWDwere 0.60 and 0.51, respectively.3 Spearman rank correlation
coefﬁcients (rho) between theWIQ distance score andmaximum6-
minwalking distance range from 0.48 to 0.56.4 In the present study,
the correlation coefﬁcients are in the range of these previous
studies and are not decreased after skipping the running item for
scoring. The small differences observed in the present study
between the coefﬁcients of correlation of the WIQ and EACH-Q and
of WIQ* and EACH-Q* with treadmill results are in the range of the
results observed previously.
There are some limitations to the present study. First, the
population studied might not be representative of patients withrvals of 10%, before and after skipping of the running item.
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might limit the generalisation of our results. Second, a high
proportion of our patients are referred for proximal claudication
to determine a vascular origin of symptoms with exercise
oximetry.18e20 This is why ABI was not taken as a standard to
deﬁne peripheral artery disease in the present study and prob-
ably the reason why the mean ABI was relatively high in our
population. Further, it could be suggested that patients with
proximal exercise-induced ischaemia are preferentially disabled
at running as compared to ‘classical’ calf claudication. We think
that it is not the case since the analysis of the sub-group of
patients not showing proximal claudication showed a similar
trend (data not shown). Third, we have no information about the
education, socio-economic status and ethnic origin of our
patients. This may have inﬂuenced our results since it was
shown that people with a low socio-economical status are more
likely to show mobility limitation than the rest of the pop-
ulation.21 Socio-economic and educational status may likely
have inﬂuenced the initial proportion of errors in the ques-
tionnaires as well as the distribution of values into the running
items. Nevertheless, we think that the fact that removing the
running item reduces the number of questionnaires with errors,
without impairing the relationship with MWD on treadmill, is
unlikely to be inﬂuenced by these socio-economic parameters.
Forth, the fact that calculating questionnaire scores after skip-
ping the running item: (i) further reduces the rate of errors in
the EACH-Q (which was already lower than with the WIQ) and
(ii) does not impair the correlation of questionnaire scores with
treadmill results, does not necessarily mean that the running
item could be removed from these questionnaires. A study
comparing the ﬁlling of two versions of the EACH-Q (one with
and one without a running item) might possibly show slightly
different results. Nevertheless, when the aim to reduce ques-
tionnaire length, it appears reasonable in our population to
remove preferentially the item dealing with running capacity.
Our idea, when designing the present study, was to limit the
time needed for self-completing the questionnaires. We thought
that having the patient ﬁll two different versions of the WIQ and
two different versions of the EACH-Q (one with and one without
a running item) would increase the risk of errors and rebuttal to
be included.Conclusions and Perspectives
The present results show that most patients in our population
report to be unable to run, and that skipping the running ques-
tion in the analysis and scoring reduces the rate of errors in the
EACH-Q. The study also shows that skipping the running item
does not impair the correlation of questionnaire score with
treadmill results. We recently reported that correcting the EACH-
Q score with a single item about usual walking speed could
improve the correlation of the EACH-Q score with treadmill
results.22 From all these observations, we think that a new
questionnaire (The WELCH: Walking estimated limitation calcu-
lated by history), based on the ﬁrst three items of the EACH-Q
(removing the running item), associated to a self-reported esti-
mation of usual walking speed, and using a pre-deﬁned speciﬁc
method of scoring that is easy to remember and can be very
easily done by mental calculation, could be build. A prospective
study of this WELCH questionnaire is currently starting on
a multi-centric basis (ClinicalTrials.gov Identiﬁer: NCT01424020).
Our ﬁnal goal is to validate this very simple four-item ques-
tionnaire, with the idea that it could be used as a routine tool by
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